Trend Analysis of Small Stocks– MCZ, GNBT, RNN, SAPX
Houston, TX –February 7, 2013– (Net PR News) – AnotherWinningTrade.com delivers quality trading ideas for the elite investor that has the financial wherewithal and market nimbleness to profit on small moves in a stock’s price. Become a member and you will be provided with real-time alerts intended to provide you with the opportunity to make profitable trades. To receive our FREE, comprehensive newsletter, visit AnotherWinningTrade.com. Stocks that are being watched this morning are: NYSEAMEX:MCZ, OTC:GNBT, NYSEAMEX:RNN, PINK:SAPX
Mad Catz Interactive, Inc. (USA) (NYSEAMEX:MCZ) reported financial results of its fiscal third quarter. Its net sales for the quarter remained$45.0 million, a decrease of 3% from the previous year quarter’s net sales of $46.2 million.
Mad Catz Interactive, Inc., during the previous trading session, showed a negative movement of -20.68%. Currently, the company has a market capitalization of $301.46 million. Stock’s closing price was $0.480 while it started its day-trade at $0.51. Its 52-week price range was $0.39 – $0.74.
How Should Investors Trade MCZ Now? Don’t Trade MCZ until You Read This TREND ANALYSIS REPORT
Year to date performance of the stock remained negative with the drop of -4%. MCZ traded with volume of 1.73 million shares, while its average trading volume remained 162,791.00 shares.
Generex Biotechnology Corporation(OTC:GNBT) remained among the day decliners and traded with volume of 7.38 million shares in the last trading session, as compared to average volume of 8.62 million shares.
How Should Investors React To GNBT Now? Find Out In This TREND ANALYSIS REPORT
The stock on Wednesday decreased -6.58% and finished the day at $0.0355. GNBT was a loser in the 5 days activity and slipped about -8.97%. The one month performance of the stock was positive and it scored more than 31%. The 52 week range of the stock remained $0.02 – $0.17.
Rexahn Pharmaceuticals, Inc. (NYSEAMEX:RNN)declared that it has appointed a new Chief Executive Officer for the company, Dr. Peter D. Suzdak will succeed Dr. Chang Ahn as CEO.
Dr. Chang Ahn will remain Chairman of the Board and also move into the role of Chief Scientist.
Rexahn Pharmaceuticals, Inc. traded with a plunge of -1.58% and closed at $0.350 after gaining total volume of 1.60 million shares. Its opening price remained $0.38.
Get a Free Report and Detailed Analysis on RNN CLICK HERE To Read
Rexahn Pharmaceuticals’ earnings per share is $-0.06 while its beta value stands at 1.39 times. If we look at the previous six month’s performance of the stock, it remained pessimistic with the loss of -28.57%. In its last one month’s trade it surged 20.69%. RNN has total market capitalization of $33.32 million with a total of 95.35 million outstanding shares.
Seven Arts Entertainment Inc (PINK:SAPX) opened at the price of $0.02, whereas its previous closing price was recorded at $0.0200. SAPX decreased -16.32% and traded within the range of $0.02 – $0.02 for the day. The 52week range of the stock remained in between $0.02 – $23.03.
Is SAPX A Solid Investment At These Levels? Find Out Exactly Where SAPX Is Headed With This TREND ANALYSIS REPORT
The Company’s total market capitalization stands at $554,149.00, along with 27.71 million outstanding shares. Total volume of the stock was 4.32 million shares during last trade, while its average volume is 1.65 million shares.
Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO News Wire twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send no faxes or emails.